Literature DB >> 7936818

Peritoneal ventilation: an animal model of extrapulmonary ventilation in experimental adult respiratory distress syndrome.

J Barr1, A Livne, G Lushkov, I Vinograd, Y Efrati, A Ballin, E Lahat, G Eshel.   

Abstract

Adult respiratory distress syndrome (ARDS) is a critical medical problem in which severe arterial hypoxemia is often poorly responsive to conventional modes of mechanical ventilation. We studied the efficiency of mechanical ventilation of the peritoneal cavity in rabbits with experimental ARDS caused by lung lavage. The study shows that peritoneal ventilation is significantly effective in oxygenation of hypoxemic animals with ARDS and is also effective for carbon dioxide elimination. Peritoneal ventilation may be considered as an investigational method for extrapulmonary oxygenation in severe intractable hypoxemia caused by ARDS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936818     DOI: 10.1203/00006450-199406000-00012

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Peritoneal ventilation in rabbits: augmentation of gas exchange with cisapride.

Authors:  J Barr; G Lushkov; S Strauss; S Gurevitch; E Lahat; T Bistritzer; B Klin; G Eshel
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

2.  Exploring alternative routes for oxygen administration.

Authors:  Elisa Damiani; Alex Dyson; Lucia Zacchetti; Abele Donati; Mervyn Singer
Journal:  Intensive Care Med Exp       Date:  2016-10-10

3.  Peritoneal perfusion with oxygenated perfluorocarbon augments systemic oxygenation.

Authors:  Shamus R Carr; Joshua P Cantor; Atul S Rao; Thiru V Lakshman; Joshua E Collins; Joseph S Friedberg
Journal:  Chest       Date:  2006-08       Impact factor: 9.410

4.  Systemic oxygen delivery by peritoneal perfusion of oxygen microbubbles.

Authors:  Jameel A Feshitan; Nathan D Legband; Mark A Borden; Benjamin S Terry
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.